Intrinsiqq
Alzamend Neuro Inc. logo

Alzamend Neuro Inc. Insider Trading

ALZN

Compare
Last 12 months

Insiders bought 221K and sold 14K on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director William B. Horne sold 7K on Dec 19, 2025, 100% of their stake, outside a plan.

Net open-market
+207K
2 buys · 3 sales
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
1 / 2
executives and directors
Last open-market buy
Apr 2026
Apr 14, 2026

Get an email when ALZN's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Aug 26No plan
    Milton C Ault III
    Director · sold 2,000 at $1.56
    3K
    1.5% of stake
  • Apr 14
    Milton C Ault III
    Director · bought 110,388 at avg $1.00
    110K
    569% of stake
  • Apr 14
    Milton C Ault III
    Director · bought 110,388 at avg $1.00
    110K
    569% of stake
  • Dec 23, 2025No plan
    Milton C Ault III
    Director · sold 1,851 at $2.07
    4K
    8.7% of stake
  • Dec 19, 2025No plan
    William B. Horne
    Director · sold 3,333 at $2.12
    7K
    100% of stake
  • Oct 23, 2025No plan
    Lynne Fahey McGrath
    Director · sold 30 at $2.29
    $69
    55% of stake
  • Oct 8, 2025 – Oct 9, 2025No plan
    Milton C Ault III
    Director · sold 121,791 at avg $2.42
    295K
    85% of stake
  • Oct 6, 2025 – Oct 7, 2025No plan
    Milton C Ault III
    Director · sold 139,412 at avg $2.47
    344K
    63% of stake
  • Oct 1, 2025 – Oct 3, 2025No plan
    Milton C Ault III
    Director · sold 123,366 at avg $2.40
    297K
    85% of stake
  • Sep 26, 2025 – Sep 30, 2025No plan
    Milton C Ault III
    Director · sold 79,628 at avg $2.31
    184K
    64% of stake
  • Sep 23, 2025 – Sep 25, 2025No plan
    Milton C Ault III
    Director · sold 97,006 at avg $2.34
    227K
    44% of stake
  • Sep 19, 2025No plan
    Milton C Ault III
    Director · sold 77,009 at $2.35
    181K
    39% of stake
  • Sep 17, 2025 – Sep 18, 2025No plan
    Milton C Ault III
    Director · sold 22,991 at avg $2.47
    57K
    19% of stake
  • Jul 30, 2025 – Jul 31, 2025No plan
    Milton C Ault III
    Director · sold 129,449 at avg $2.29
    296K
    86% of stake
  • Jul 25, 2025 – Jul 28, 2025No plan
    Milton C Ault III
    Director · sold 44,843 at avg $2.86
    128K
    47% of stake
  • Jul 23, 2025 – Jul 24, 2025No plan
    Milton C Ault III
    Director · sold 69,137 at avg $2.95
    204K
    42% of stake
  • May 12, 2025No plan
    Milton C Ault III
    Director · sold 1,224 at avg $5.06
    6K
    5.5% of stake
  • Mar 26, 2025
    William B. Horne
    Director · bought 3,334 at $0.99
    3K
    13% of stake
  • Mar 21, 2025
    Milton C Ault III
    Director · bought 2,905 at $1.02
    3K
    1.5% of stake
  • Mar 21, 2025
    David J Katzoff
    Chief Financial Officer · bought 5,000 at $1.01
    5K
    926% of stake
  • Mar 20, 2025
    William B. Horne
    Director · bought 5,000 at $0.98
    5K
    23% of stake
  • Mar 18, 2025
    William B. Horne
    Director · bought 5,000 at $0.97
    5K
    30% of stake
  • Mar 18, 2025
    Milton C Ault III
    Director · bought 5,000 at $0.96
    5K
    2.6% of stake
  • Mar 12, 2025
    Milton C Ault III
    Director · bought 100 at $0.68
    $68
    <0.1% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ALZN, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with ALZN

CompareIntrinsic value
LIPOLipella Pharmaceuticals Inc.
$0.00+0.00%25
CARMCarisma Therapeutics Inc.
$0.00+0.00%60
SLNOSoleno Therapeutics Inc
No recent price25
OPKOpko Health Inc.
$1.57-2.48%28
IBIOiBio, Inc.
$0.80+0.01%10
LFVNLifeVantage Corporation
$4.15-15.13%68
PAHCPhibro Animal Health Corporation
$33.29-2.32%57

Spot a number that looks wrong? Check it in ALZN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing ALZN

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.